
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106414 - 106414
Published: Nov. 1, 2024
Language: Английский
Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106414 - 106414
Published: Nov. 1, 2024
Language: Английский
European Journal of Pharmaceutical Sciences, Journal Year: 2025, Volume and Issue: 207, P. 107034 - 107034
Published: Feb. 6, 2025
Indocyanine green J-aggregate (IJA) is a promising photothermal (PTT) agent that has recently been utilised in preclinical studies for cancer diagnostics and treatment. The unique properties, such as the red-shift absorption band longer wavelengths, are behind IJA's superior thermal stability compared to its monomeric ICG. Loading IJA into nanoparticles (NPs) proven advantageous enhancing vivo targeting of various models. However, loading more complex lipids, lipid nanocapsules (LNCs) solid (SLNs), not reported. present work focuses on investigations effect formulation parameters pre-formed (p-IJA) formation p-IJA-loaded LNCs SLNs, thus their theranostic applications. We investigated shell core SLN p-IJA stability. Our findings demonstrated significant role lipophilic surfactants (Span 85) high-melting-point (sodium stearate) ratio heating capacity following SLNs. More importantly, p-IJA-SLN enhanced optical range biological media, serum proteins, blood, collagen. Furthermore, lyophilised p-IJA-SLNs were successfully obtained after long-term storage. Overall, NPs could provide platform applications, including photoacoustic imaging, PTT, photodynamic therapy (PDT), combination with chemotherapeutics.
Language: Английский
Citations
1International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2633 - 2633
Published: March 14, 2025
Cancer is one of the main causes death worldwide. Chemotherapy, radiotherapy and surgery are currently treatments choice for cancer. However, conventional therapies have their limitations, such as non-specificity, tumor recurrence toxicity to target cells. Recently, nanomaterials been considered therapeutic agents against This mainly due unique optical properties, biocompatibility, large surface area nanoscale size. These properties crucial they can affect biocompatibility uptake by cell, reducing efficacy. because nanoparticles be functionalized with biomolecules, become more biocompatible, which improves uptake, specifically targeted cancer cells, anticancer activity. In this review, we summarize some recent studies in aim increasing efficacy treatment.
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 106414 - 106414
Published: Nov. 1, 2024
Language: Английский
Citations
0